Prof. Pascal Marchand received a PhD (1999) in Medicinal Chemistry from the University of Nantes, France. He was appointed as an Assistant Professor (2001) in Organic Chemistry, within the School of Pharmacy. Pascal obtained his Habilitation (2007) in the design, synthesis and biological evaluation of azaheterocyclic compounds and, since 2013, he is a full Professor of Organic Chemistry in the School of Pharmacy, University of Nantes. He is currently deputy director of the UR 1155 - IICiMed team of the University of Nantes - France (January 2017) and head of the MedChem department. His main research field is focused on the design, synthesis and biological evaluation of heterocyclic compounds for therapeutic purposes (mycology, parasitology and cancer) by targeting kinase-signalling pathways, through the supervision of 17 PhD students and 8 Postdoctoral programmes in the frame of industrial collaborations, French academic collaborations and international joint supervisions. He managed various international collaborative projects (CAPES-COFECUB Brazil, PHC Ulysses Ireland and CONACyT Mexico). He is President of a European research network (GP2A: Group for the Promotion of Pharmaceutical Chemistry in Academia) and he is a board member of the French Medicinal Chemistry Society. Pascal is co-author of 61 international publications and 4 international patents and he was invited to deliver 23 conferences in international meetings.Recently (2021), his research has attracted funding from the French National Research Agency (ANR) to coordinate a 4-year project dedicated to antiparasite chemotherapy and entitled: Targeting host-parasite interactions through the inhibition of EXcreted LEISHmania casein kinase 1 (TEXLEISH).